# US 2004/0083447 A1 · 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0083447 A1
- Document ID: US20040083447A1
- Status: Published application
- Kind: A1
- Application number: 10/667,821
- Filed: 2003-09-22
- Published: 2004-04-29
- Earliest claimed: 1997-01-30
- Assignees: Neurogen Corporation, A Corporation of the State of Delaware
- Inventors: Andrew Thurkauf; Xi Chen
- Web page: https://patentgrep.com/patent/US20040083447A1

## CPC

- C07D 295/073: with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A61K 31/495: having six-membered rings with two {or more} nitrogen atoms as the only ring heteroatoms, e.g. piperazine {or tetrazines}(A61K31/48 takes precedence {; with three nitrogen atoms A61K31/53})
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 295/096: with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D 295/112: with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D 295/135: with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07C 2603/08: containing three- or four-membered rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Disclosed are compounds of the formula: 1 or the pharmaceutically acceptable addition salts thereof wherein: R1 is halogen or C1-C4 alkyl; and R2 and R3 are the same or different and represent hydrogen, halogen, C1-C4 alkyl, C1-C4 alkoxy, alkylthio, hydroxy, amino, mono(C1-C4)alkylamino, di(C1-C4)alkylamino, or R2 and R3 together represent a 4 carbon alkenylene moiety that together with the phenyl ring to which they are attached form a naphthyl moiety, which compounds are useful in the treatment of neuropsycological diseases such as schizophrenia, psychotic depression and mania.

## Claims

### Claim 1

A compounds of the formula:
12
or the pharmaceutically acceptable acid salts thereof wherein:
R1 is halogen or C1-C4 alkyl;
R2 and R3 are the same or different and represent hydrogen, halogen, C1-C4 alkyl, C1-C4 alkoxy, alkylthio, hydroxy, amino, monoalkylamino or dialkylamino,
with the proviso that R2 and R3 may not be 2-isopropoxyl and hydrogen respectively when R1 is bromo.

### Claim 2 (depends on 1)

A compound according to claim 1, wherein R1 is methyl.

### Claim 3

A compound of the formula:
13
or the pharmaceutically acceptable salts thereof wherein
Rx is fluorine, chlorine, bromine, or iodine; and
R2 and R3 are the same or different and represent hydrogen, halogen, C1-C4 alkyl, C1-C4 alkoxy, alkylthio, hydroxy, amino, monoalkylamino or dialkylamino.

### Claim 4 (depends on 3)

A compound according to claim 3, wherein R2 and R3 may not be 2-isopropoxyl and hydrogen, respectively, when R1 is bromo.

### Claim 5 (depends on 3)

A compound according to claim 3, wherein Rx is chloride; R2 and R3 may not be 2-isopropoxyl and hydrogen, respectively, when R1 is bromo; R2 is chloride, methyl or methoxy; and R3 is hydrogen or methyl.

### Claim 6 (depends on 5)

A compound according to claim 5, wherein the phenyl group substituted with R2 and R3 is selected from the group consisting of:
14

### Claim 7

A compound of the formula:
15
or the pharmaceutically acceptable salts thereof wherein
Ra is C1-C4 alkyl; and
R2 and R3 are the same or different and represent hydrogen, halogen, C1-C4 alkyl, C1-C4 alkoxy, alkylthio, hydroxy, amino, monoalkylamino or dialkylamino.

### Claim 8 (depends on 7)

A compound according to claim 7, wherein R1 is methyl.

### Claim 9 (depends on 1)

A compound of according to claim 1, wherein R2 is chloride, fluoride, methyl or methoxy; and R3 is hydrogen or methyl.

### Claim 10 (depends on 8)

A compound according to claim 8, wherein the phenyl group substituted with R2 and R3 is selected from the group consisting of:
16

### Claim 11

A compound of the formula:
17
or the pharmaceutically acceptable salts thereof wherein:
R1 is C1-C4 alkyl or halogen.

### Claim 12 (depends on 11)

A compound according to claim 11, wherein R1 is chloro.

### Claim 13 (depends on 1)

A compound according to claim 1, which is 1-(3-chlorophenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 14 (depends on 1)

A compound according to claim 1, which is 1-(2-chlorophenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 15 (depends on 1)

A compound according to claim 1, which is 1-3,4-dichlorophenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 16 (depends on 1)

A compound according to claim 1, which is 1-(4-methylphenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 17 (depends on 1)

A compound according to claim 1, which is 1-3-methylphenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 18 (depends on 1)

A compound according to claim 1, which is 1-(2-methylphenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 19 (depends on 1)

A compound according to claim 1, which is 1-(3,4-dimethylphenyl)-4-(4-chlorobenzyl)piperazine dihydrobromide.

### Claim 20 (depends on 1)

A compound according to claim 1, which is 14-methoxyphenyl)-4-(4-chlorobenzyl)piperazine dihydrobromide.

### Claim 21 (depends on 1)

A compound according to claim 1, which is 1-(3-methoxyphenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 22 (depends on 1)

A compound according to claim 1, which is 1-(2-methoxyphenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 23 (depends on 1)

A compound according to claim 1, which is 1-(4-ethoxyphenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 24 (depends on 1)

A compound according to claim 1, which is 1-(2-ethoxyphenyl)-4-(4-chlorobenzyl)piperazine.

### Claim 25 (depends on 1)

A compound according to claim 1, which is 1-phenyl-4-(4-chlorobenzyl)piperazine.

### Claim 26 (depends on 1)

A compound according to claim 1, which is 1-(4-chlorophenyl)-4-(4-fluorobenzyl)piperazine.

### Claim 27 (depends on 1)

A compound according to claim 1, which is 1-(4-chlorophenyl)-4-(4-methylbenzyl)piperazine.

### Claim 28 (depends on 1)

A compound according to claim 1, which is 1-(3-chlorophenyl)-4-(4-methylbenzyl)piperazine.

### Claim 29 (depends on 1)

A compound according to claim 1, which is 1-(3,4-dichlorophenyl)-4-(4-ethylbenzyl)piperazine.

### Claim 30 (depends on 1)

A compound according to claim 1, which is 1-(4-methylphenyl)-4-(4-methylbenzyl)piperazine.

### Claim 31 (depends on 1)

A compound according to claim 1, which is 1-(2-methylphenyl)-4-(4-methylbenzyl)piperazine.

### Claim 32 (depends on 1)

A compound according to claim 1, which is 1-(4-methoxyphenyl)-4-(4-methylbenzyl)piperazine.

### Claim 33 (depends on 1)

A compound according to claim 1, which is 1-(2-methoxyphenyl)-4-(4-methylbenzyl)piperazine.

### Claim 34

A method for treating or preventing neuropsychological disorders which comprises administering to a patient in need of such treatment a compound selected from the group consisting of
(a) 1-(3-chlorophenyl)-4-(4-chlorobenzyl)piperazine;
(b)-(2-chlorophenyl)-4-(chlorobenzyl)piperazine;
(c) 1-(3,4-dichlorophenyl)-4-chlorobenzyl)piperazine;
(d) 1-(4-methylphenyl)-4-(4-chlorobenzyl)piperazine;
(e) 1-(3-methylphenyl)-4-(4-chlorobenzyl)piperazine;
(f) 1-(2-methylphenyl)-4-(4-chlorobenzyl)piperazine;
(g) 1-(3,4-dimethylphenyl)-4-(chlorobenzyl)piperazine;
(h) 1-(4-methoxyphenyl)-4-(4-chlorobenzyl)piperazine;
(i) 1-(3-methoxyphenyl)-4-(4-chlorobenzyl)piperazine;
(j) 1-(2-methoxyphenyl)-4-(4-chlorobenzyl)piperazine;
(k) 1-(4-ethoxyphenyl)-4-(4-chlorobenzyl)piperazine;
(l) 1-(2-ethoxyphenyl)-4-(4-chlorobenzyl)piperazine;
(m) 1-phenyl-4-4-chlorobenzyl)piperazine;
(n) 1-(4-chlorophenyl)-4-(4-fluorobenzyl)piperazine;
(o) 1-(4-chlorophenyl)-4-(4-methylbenzyl)piperazine;
(p) 1-(3-chlorophenyl)-4-(4-methylbenzyl)piperazine;
(q) 1-(4-chlorophenyl)-4-(4-methylbenzyl)piperazine;
(r) 1-(3,4-dichlorophenyl)-4-(4-methylbenzyl)piperazine;
(s) 1-(4-methylphenyl)-4-(4-methylbenzyl)piperazine;
(t) 1-(2-methylphenyl)-4-(4-methylbenzyl)piperazine;
(u)-methoxyphenyl)-4-(methylbenzyl)piperazine;
(v)-methoxyphenyl)-4-(4-methylbenzyl)piperazine;
(w) 1-(4-chlorophenyl)-4-chlorobenzyl)piperazine dihydrochloride; and
(x)-(2-isopropoxyphenyl)-4-(4-bromobenzyl)piperazine.

### Claim 35 (depends on 1)

A compound according to claim 1, which is 1-Naphthyl-4-(4-chlorobenzyl)piperazine.
